Senior Director, Pipeline Market Access Strategy - Oncology

Key Responsibilities

Pipeline Access Strategy & Portfolio Leadership

• Owns the end-to-end pipeline Integrated access strategy for all pre-launch and development-stage assets within the assigned Business Unit, ensuring strategies are comprehensive in addressing evidence needs, policy considerations, pricing potential, and commercial considerations.
• Serves as the primary voice of pipeline market access strategies at Business Unit governance forums, including LMG, TASC, CSM, ASTs, and other senior leadership reviews.
• Serves as the voice of access into pipeline Business Development opportunities.
• Leads prioritization exercises across the pipeline portfolio to ensure resources and strategic attention are allocated to assets with the greatest near- and long-term access complexity and business impact.
• Creates and optimizes launch strategies inclusive of considerations for IRA, MFN, and other market forces (US Channel dynamics).
• Defines and delivers the Access Roadmap—a cross-functionally developed strategy that articulates the access approach for each pipeline asset by development phase, anticipated launch timing, and global evidence deliverables.

Early Development Integration

• Partners with R&D and Regulatory teams to embed access-relevant endpoints, comparators, and trial design elements into clinical development programs from Phase I/II onward.
• Defines and champions Target Product Profiles (TPPs) from a market access perspective, translating payer value requirements into actionable clinical and evidence generation guidance for asset teams.
• Generates and maintains global payer and HTA evidence requirements across major markets (US, EU5, Japan, and emerging markets).

US & International Strategy Alignment

• Provides strategic leadership and direction to the US Pipeline Strategy Lead and International Pipeline Strategy Lead.
• Aligns US payer strategy, formulary positioning, and value communication frameworks with international HTA, pricing, and reimbursement approaches.
• Anticipates cross-market reference pricing dynamics, parallel trade risks, and HTA precedent effects.
• Partners closely with US and International Pipeline Strategy Leads to develop and execute a structured pipeline-to-launch transition framework.
• Collaborates with US and international commercial, medical, and market access teams to ensure seamless knowledge transfer and strategic handoff at the point of regulatory approval.
• Leads cross-functional launch readiness reviews in partnership with US and International teams to identify and resolve access gaps prior to approval.
• Ensures that affiliate and in-country market access teams are equipped with globally aligned value messages, health economic tools, and reimbursement dossiers well in advance of launch.

Cross-Functional Leadership & Partnership

• Provides strategic direction and partnership to cross-functional groups including HEOR, R&D, Regulatory, Global Commercial Development, Global Marketing, Government Affairs, and Business Development.
• Leads the development of Integrated Evidence Plans (IEPs) in close collaboration with HEOR.
• Partners with Government Affairs to anticipate and shape the evolving policy and reimbursement landscape.
• Collaborates with Global Commercial Development and Global Marketing to ensure pipeline access strategies are aligned with brand positioning, indication sequencing, and long-range commercial forecasts.

Business Development & Asset Evaluation

• Works closely with Business Development to inform the market access potential of in-licensing, partnership, and acquisition opportunities.
• Establishes and communicates access-based licensing priorities.
• Serves as the access subject matter expert in due diligence processes.

Governance, Stakeholder Engagement & People Leadership

• Represents pipeline market access priorities at senior leadership governance forums, portfolio review committees, and cross-Business Unit strategy sessions.
• Builds, develops, and retains a high-performing pipeline access team, providing mentorship, career development, and performance management.
• Fosters a culture of innovation, rigor, and affiliate-centricity within the pipeline access team.

Qualifications

An advanced degree (MBA, MPH, PhD, PharmD, or equivalent) in business, health economics, public policy, life sciences, or a related field is required. Formal training or demonstrated expertise in health technology assessment (HTA), health economics, outcomes research, or pharmaceutical development is strongly preferred. Bachelor's degree in a scientific, business, or public health discipline is required as a minimum baseline.

A minimum of 12–15 years of progressive, senior-level experience in market access, pricing, reimbursement, HEOR, or a closely related pharmaceutical/biopharmaceutical function — with a substantial portion of that experience focused on pipeline and pre-launch strategy. Demonstrated expertise in global market access, including a deep working knowledge of HTA processes, payer evidence requirements, pricing and reimbursement frameworks, and access decision-making dynamics across major international markets. Proven experience shaping clinical development strategy from a market access and outcomes evidence perspective. Strong track record of leading and developing high-performing teams in a matrixed, multinational environment. Experience supporting Business Development activities is highly preferred. Experience across multiple therapeutic areas is an asset, though deep expertise in at least one is required.